Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Get email alerts on the 340B Program topic
No spam. Unsubscribe anytime.
Committee schedules markup for 340B provisions after extensive testimony from hospitals, FQHCs and other stakeholders
Summary
Committee members scheduled a markup for 340B‑related language (referred to as 3:40 b) after receiving testimony from hospitals, FQHCs, Planned Parenthood, insurers and pharmaceutical stakeholders.
Committee members scheduled a markup session to begin formal consideration of provisions related to the 340B program (referred to during the meeting as 3:40 b) after hearing multiple rounds of testimony.
Committee staff said they had taken testimony from hospitals, federally qualified health centers (FQHCs), Planned Parenthood, insurers and pharmaceutical representatives. A staffer reported outreach to a contract pharmacy but said the committee was unable to secure testimony from that party.
Members discussed the range of stakeholder perspectives and asked whether additional witnesses were needed before markup. With no further parties identified for testimony, the committee directed staff to schedule a markup session the following day after the floor session. The chair indicated the markup would begin about 11:30 a.m., pending counsel availability.
Members emphasized the limited time before crossover and agreed to prioritize 340B markup alongside H.80 and workplace violence work. The committee did not take a formal vote on policy during the session; members instructed staff to prepare the draft for markup.
